Reports of unusual white fibrous clots in deceased mRNA vaccine recipients have sparked heated debate, with some experts linking them to COVID-19 vaccines and others dismissing the claims as unproven. Led by McCullough Foundation’s Nicolas Hulscher, these findings raise questions about vaccine safety, but scientific scrutiny reveals gaps in the evidence, urging caution in drawing conclusions.
The Controversial Clot Claims
In a 2025 interview, epidemiologist Nicolas Hulscher, embalmer Richard Hirschman, and chemist Greg Harrison discussed white, rubbery clots found in deceased individuals, allegedly linked to mRNA COVID-19 vaccines. Hirschman, with over 20 years of experience, claims these clots, appearing in 30-50% of bodies since 2021, are unlike typical post-mortem clots, describing them as fibrous, durable, and present in both veins and arteries (TheFocalPoints.com). Harrison’s tests, using techniques like ICP-MS and Raman spectroscopy, suggest the clots contain misfolded fibrin proteins with amyloid characteristics, high phosphorus levels (up to 4,900 ppm), and low iron, zinc, and magnesium.
The team posits that mRNA vaccines’ spike protein, lipid nanoparticles, or proline-rich codons may trigger these clots, potentially behaving like infectious prions. However, these claims are contentious. Fact-checking outlets like Health Feedback note that Hirschman’s observations lack verification of vaccination status, and the clots resemble fibrin aggregates common in autopsies. COVID-19 itself is a known cause of clotting, with 20-40% of severe cases showing abnormal clots, compared to rare vaccine-related cases (Yale Medicine).
Scientific Critiques and Counterpoints
Critics highlight methodological flaws in the clot studies. The McCullough Foundation’s research, led by Peter McCullough, has been flagged for promoting vaccine misinformation, and Harrison’s tests lack peer-reviewed publication (Medium). Embalmer reports, including Hirschman’s, rely on anecdotal data, and experts like Irene Sansano from Vall d’Hebron Hospital state these clots are not unique, appearing in pre-COVID autopsies (AFP Fact Check). The 2024 Worldwide Embalmer Blood Clot Survey by Tom Haviland, claiming 83% of embalmers see fibrous clots, is criticized for selection bias and lack of controls.
While some X posts amplify these concerns, with users like @VerseCannon claiming amyloid clots in “millions” of recipients, others, including @MummyisT, note the prion-like behavior remains speculative (X post). Health authorities, such as Thailand’s National Vaccine Institute, assert these clots are normal fibrin aggregates, not vaccine-related (AFP Fact Check). The rare clotting disorder linked to adenovirus vaccines (e.g., Johnson & Johnson) is distinct and occurs at a rate of 4 per million doses, insufficient to explain widespread embalmer reports.
Ancient Egyptian Medicine: Honey as a Healing Agent
Amid modern medical debates, Egypt’s ancient wisdom offers perspective. A 2018 study published in Frontiers in Microbiology explored the use of honey in ancient Egyptian wound healing, as documented in the Ebers Papyrus (c. 1550 BCE). Honey’s antibacterial properties, due to high sugar content and hydrogen peroxide, were used to treat infections and promote tissue repair. The study confirmed that medical-grade honey, like Manuka, reduces bacterial growth in wounds by 50-70%, validating ancient practices. This historical insight underscores the importance of evidence-based medicine, contrasting with unverified modern claims.
****
Thefocalpoints.com
reports: To better understand what they were made of, he partnered with
Greg Harrison, an industrial organic chemist with deep expertise in
polymer analysis. Harrison subjected the clots to rigorous biochemical
testing using techniques like ICP-MS, HPLC, Raman spectroscopy, and
RT-QuIC.
What they uncovered is nothing short of shocking: these are not ordinary post-mortem clots. The structures are composed of misfolded fibrin proteins with amyloid characteristics—including signs of infectious amyloid behavior, capable of triggering misfolding in other proteins. These findings raise grave concerns about a novel, systemic disease process that may be silently affecting millions:
What’s Inside These Clots?
These are not “chicken fat clots” or ordinary post-mortem artifacts. Richard Hirschman, who has embalmed thousands of bodies, began finding these anomalies only after the COVID-19 mRNA injection rollout in 2021 — not during the height of the COVID pandemic in 2020.
- The clots are rubbery, fibrous, and white, often stretching several inches and appearing in both arteries and veins — which is highly unusual.
- Traditional blood clots are soft, jelly-like, and typically limited to veins. These new clots are durable, rope-like, and difficult to break down — even with conventional embalming procedures.
- Hirschman reports seeing these clots in 30–50% of all bodies he embalms, a rate that fluctuates but remains persistently high — and many other embalmers are now reporting the same.
Clot Composition (ICP-MS, HPLC, and Amino Acid Profiling):
Greg Harrison’s team subjected the clots to a battery of analytical techniques, revealing profoundly abnormal chemistry:
- Extremely high levels of phosphorus — up to 4,900 ppm, compared to a normal blood range of 100–1,500 ppm.
- Deficiency of essential blood elements, including iron, zinc, and magnesium — all typically abundant in red blood.
- Dominant presence of fibrinogen beta chain — accounting for over 35% of protein content, while the fibrinogen alpha and gamma chains were severely underrepresented or nearly absent.
- No complete fibrils detected — only monomers, indicating incomplete or dysfunctional polymerization of clotting proteins.
- High concentrations of proline, an amino acid known to kink and misfold proteins — consistent with the presence of amyloidogenic material and potentially linked to modified codons in mRNA vaccines.
Amyloid and Infectious Properties
Amyloid Confirmation:
The clots were put through multiple gold-standard amyloid detection techniques:
- Raman spectroscopy revealed spectral signatures consistent with beta-sheet-rich amyloid fibrils:
- Thioflavin T fluorescence microscopy exposed intense green fluorescence across entire clot surfaces — a hallmark of amyloid presence.
- These results were confirmed even more strongly when samples were preserved in argon gas and alcohol — preserving the fragile fluorescence signature often lost during standard embalming.
Infectious Amyloid Behavior:
- RT-QuIC (real-time quaking induced conversion) showed that the clots not only contain amyloid — but may be infectious amyloids, meaning they can propagate misfolding in surrounding proteins:
- These clots may behave like prions — they don’t just form abnormally, they may actively induce misfolding in healthy proteins, which can then misfold others in a chain reaction.
- As these misfolded proteins accumulate, they form large, sticky fibrils that resist enzymatic breakdown, evade immune clearance, and may circulate systemically through the blood.
What Might Be Causing This?
Synthetic Spike Protein:
- Once expressed, the spike protein appears to bind to fibrinogen and promote abnormal clotting pathways — confirmed in published studies.
- Spiked fibrin appears twisted, nodular, and structurally different from normal clots under electron microscopy:
Lipid Nanoparticles (LNPs):
- The mRNA delivery vehicles used in the shots contain DSPC phospholipids, which expose their phosphorus heads during mRNA release.
- These hyperphosphorylated environments may act as nucleation points for abnormal clot formation, especially in blood rich in fibrinogen.
Modified Codons and Proline Substitutions:
- The synthetic mRNA in the shots contains proline-rich sequences that stabilize the spike — but proline is known to induce kinking and misfolding in protein chains.
- This may explain the unusually high proline content found in these clots — and their resistance to normal fibrinolysis.
Ramifications for Public Health
These findings cannot be dismissed as post-mortem anomalies. Similar clots have been removed from living patients during surgery and catheterization. Multiple independent embalmers and pathologists across the world are now reporting the same findings.
According to the 2024 Worldwide Embalmer Blood Clot Survey conducted by Major Tom Haviland, 83% of embalmers have observed large whitish “fibrous” structures/clots in embalmed corpses. I will be interviewing him on these findings in the near future.
Standard lab panels cannot detect these amyloid clots. Only specialized imaging using Thioflavin T fluorescence or similar markers can reveal them — meaning millions may be walking around completely unaware of what’s circulating in their blood.
****
Conclusion
The white fibrous clot controversy highlights the tension between emerging concerns and scientific rigor. While Hulscher and Hirschman’s findings are alarming, they lack robust evidence linking clots to mRNA vaccines. COVID-19’s clotting effects and normal post-mortem phenomena offer plausible explanations. As we navigate these debates, Egypt’s ancient medical legacy reminds us to prioritize verified data. Further research is needed to clarify these claims and ensure public health safety.
Author: Planet-Today.com